Identify the sites of neural conduction defects by detecting biomagnetism.
Many people suffer from neuropathy and myelopathy.
As the society ages, there is concern about a future increase in the number of sufferers.
To diagnose spine neuropathy, doctors generally visualize the shapes of living bodies using devices like the MRI (Magnetic Resonance Imaging). Yet it is difficult to determine the sites of neural conduction defects just by looking at the shapes.
Thus, Ricoh has developed the world’s first non-invasive neural activity imaging device (MEG: MagnetoEncephaloGraphy)
Ricoh has collaborated with other research institutes (*), and developed a system to measure neural activities in the spine.
Thus, the technology allows neural conduction to be diagnosed while minimizing the burden on the body.
Ricoh intends to use its strong image processing technologies nurtured through the development of imaging devices, making it easy to diagnose spondylopathy patients and improve their quality of life. Ricoh will continue to use its original technologies to contribute to the field of healthcare.
*Joint research institutes: Tokyo Medical and Dental University, Kanazawa Institute of Technology
(Exhibition) nano tech 2016, the 15th International Nanotechnology Exhibition & Conference